BETA Technologies, Inc. (BETA) Stock Price & Analysis
BETA Technologies, Inc. (BETA) closed at USD 19.98 on Wednesday, October 28, 2026, down 3.71% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 20.75; the Oct 28, 2026 session ranged USD 19.83–21.05 on volume of 1,576,073 shares. Market capitalization is $4.67B, with a 52-week range of USD 13.43–39.5 (NYQ). Source: Nexqual, retrieved October 29, 2026 at 07:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BETA.md
Key facts (BETA)
- Last four reported quarters (through Jun 30, 2026): revenue $44.8M, net income -$858M (-1913.9% margin), free cash flow -$422M (SEC filings).
- Insider open-market sales, last ~7 months: 26 Form 4 filings, $18.3M; 6 not under a Rule 10b5-1 plan ($2.5M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 2 Form 4 filings, $753K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 1.67 on a 1–5 scale) (9 analysts), mean target USD 32.22 (range 28–37).
- Total return with dividends: 1Y -44.5% vs S&P 500 +13.6%; 5Y -37.6% vs S&P 500 +79.8%.
- Next earnings: 2026-11-03, EPS estimate USD -0.62, revenue estimate $10.8M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BETA)
| USD | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|
| Revenue | $15.4M | $15.1M | $35.6M | $44.8M |
| Gross profit | $13.3M | $10.6M | $25.7M | — |
| Operating income | -$187M | -$272M | -$373M | -$506M |
| Net income | -$176M | -$276M | -$746M | -$858M |
| EPS (diluted) | -$4.50 | -$6.77 | -$12.85 | — |
| Free cash flow | -$311M | -$296M | -$313M | -$422M |
| Gross margin | 86.8% | 70.1% | 72.2% | — |
| Operating margin | -1214.9% | -1803.7% | -1046.3% | -1129.3% |
| Net margin | -1143.2% | -1826.4% | -2094.2% | -1913.9% |
| Revenue growth | — | -1.7% | +136.0% | — |
| Cash + short-term investments | $254M | $301M | $1.71B | — |
| Total debt | — | $152M | $186M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (BETA)
P/S 104.2x · EV/Sales 75.3x · P/B 2.9x · FCF yield -9.02% · Earnings yield -18.36% · Net cash $1.30B · EV $3.38B
Insider sales (SEC Form 4, open-market, last ~7 months) (BETA)
20 of 26 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-23…2026-10-27 | Clark Kyle | SEE REMARKS | 30,000 | $597K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-10-20…2026-10-22 | Clark Kyle | SEE REMARKS | 30,000 | $559K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-10-15…2026-10-19 | Clark Kyle | SEE REMARKS | 30,000 | $550K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-10-12…2026-10-14 | Clark Kyle | SEE REMARKS | 30,000 | $560K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-10-07…2026-10-09 | Clark Kyle | SEE REMARKS | 30,000 | $612K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-10-02…2026-10-06 | Clark Kyle | SEE REMARKS | 30,000 | $640K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-09-29…2026-10-01 | Clark Kyle | SEE REMARKS | 30,000 | $673K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-09-24…2026-09-26 | Clark Kyle | SEE REMARKS | 30,000 | $705K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-08-19…2026-08-21 | Clark Kyle | SEE REMARKS | 83,205 | $2.1M | 1.1% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-08-14…2026-08-18 | Clark Kyle | SEE REMARKS | 77,800 | $2.0M | 1% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-08-12…2026-08-13 | Clark Kyle | SEE REMARKS | 45,000 | $1.1M | 0.6% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-08-07…2026-08-11 | Clark Kyle | SEE REMARKS | 47,896 | $1.1M | 0.6% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-07-16 | Clark Kyle | SEE REMARKS | 5,000 | $88K | 0.1% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-07-13…2026-07-15 | Clark Kyle | SEE REMARKS | 45,000 | $810K | 0.6% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-07-01…2026-07-02 | Clark Kyle | SEE REMARKS | 30,000 | $530K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-29…2026-06-30 | Clark Kyle | SEE REMARKS | 30,000 | $495K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-24…2026-06-26 | Clark Kyle | SEE REMARKS | 45,000 | $722K | 0.6% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-18…2026-06-23 | Clark Kyle | SEE REMARKS | 45,000 | $713K | 0.6% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-18…2026-06-23 | Clark Kyle | SEE REMARKS | 45,000 | $713K | 0.6% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-16…2026-06-17 | Clark Kyle | SEE REMARKS | 30,000 | $479K | 0.4% | Yes | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (BETA)
2 purchases, $753K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-01…2026-09-02 | Stone Michael Robert | Director | 25,945 | $503K | 19.38 | Too little history (no open-market trades in 2023–2025) |
| 2026-05-19 | Stone Michael Robert | Director | 17,135 | $250K | 14.59 | Too little history (no open-market trades in 2023–2025) |
Analysts (BETA)
Consensus Buy (mean 1.67 on a 1–5 scale), 9 analysts; mean target USD 32.22 (low 28, high 37).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-21 | Needham | Reiterated | Buy | $34 |
| 2026-10-09 | Barclays | Initiated | Overweight | $35 |
| 2026-10-05 | Cantor Fitzgerald | Reiterated | Overweight | $31 |
| 2026-08-13 | Cantor Fitzgerald | Reiterated | Overweight | $31 |
| 2026-08-13 | BTIG | Reiterated | Buy | $33 |
| 2026-08-12 | Needham | Reiterated | Buy | $34 |
Total return (dividends reinvested) (BETA)
| 1Y (from 2025-11-04) | 5Y (from 2025-11-03) | |
|---|---|---|
| Total return | -44.5% | -37.6% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | -45.2% | -38.0% |
| Volatility (annualized) | 75.7% | 73.3% |
| Max drawdown | -63.1% (Nov 2025→Mar 2026) | -56.0% (Nov 2025→Mar 2026) |
BETA earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Aug 12, 2026 | Quarter ended Jun 30, 2026 | −$0.46 | −$0.56 | Beat +17.9% | +6.7% |
| May 12, 2026 | Quarter ended Mar 31, 2026 | −$0.40 | −$0.74 | Beat +45.9% | -0.9% |
| Mar 9, 2026 | Quarter ended Dec 31, 2025 | −$1.71 | −$0.47 | Miss −263.8% | +3.7% |
| Dec 4, 2025 | Quarter ended Sep 30, 2025 | −$1.94 | −$0.44 | Miss −340.9% | -3.8% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
BETA recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Aug 14, 2026 | Schedule 13G/A | Charles A. Davis: 7.3% of shares, passive 5%+ holder (amended) |
| Aug 14, 2026 | Schedule 13G/A | Austin Meyer: 5.4% of shares, passive 5%+ holder (amended) |
| Aug 12, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Aug 12, 2026 | 8-K | Quarterly results |
| Jul 22, 2026 | 8-K | Ended a material agreement “On July 14, 2026, BETA Technologies, Inc. (the "Company") received notice from the Defense Counterintelligence and Security Agency ("DCSA") that the Security Control Agreement (the "SCA"), dated June 15, 2025, by and among QIA Industrials Holding, LLC ("QIA"), the Company, and the U.S. Department of Defense, is no longer required and has been terminated. The SCA was put in place to mitigate foreign ownership, control, or influence considerations arising from QIA's prior board representation. Because QIA no longer…” |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
BETA revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Service | $11.4M | 77.6% | +232.5% |
| Product | $3.3M | 22.4% | +28.9% |
| Total revenue | $14.7M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
BETA suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | UNITED THERAPEUTICS Corp (UTHR) | “We have also completed successful cargo and logistics demonstrations with medical partners and customers such as UPS and United Therapeutics Corporation ("United Therapeutics").” |
| Customer | UPS (UPS) | “(1)selling aircraft to military and commercial customers such as UPS, Air New Zealand and United Therapeutics;” |
| Customer | UPS and United Therapeutics | “We have also completed successful cargo and logistics demonstrations with medical partners and customers such as UPS and United Therapeutics Corporation ("United Therapeutics").” |
| Partner | GE Aerospace (GE) | “•our exposure to adverse effects from our GE Aerospace partnership and future alliances;” |
Quoted from the company's 10-K filed Mar 9, 2026.
Companies that name BETA in their SEC reports
| Relationship to BETA | Company | Filing | Sentence |
|---|---|---|---|
| partner | York Space Systems Inc. (YSS) | 10-K Mar 20, 2026 | “Since September 2023, General McConville has been an Operating Partner at AE Industrial Partners, and has served on the board of Redwire Corporation (NYSE: RDW) since October 2025 and on the board of BETA Technologies, Inc. (NYSE: BETA) since October 2024.” |
| partner | Bristow Group Inc. (VTOL) | 10-K Feb 26, 2026 | “In February 2026, Bristow completed its first electric aviation test project, conducted as an international test arena alongside partners BETA Technologies, Inc. ("Beta"), Avinor and Norway CAA, using BETA's ALIA CX300 aircraft.” |
BETA customer concentration
In the period ended Jun 30, 2026, 4 direct customers each accounted for at least 10% (43%, 17%, 11%, 11%) of revenue, per the company's 10-Q filed Aug 12, 2026. The company does not name them.
BETA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.61 | $-0.51 | −$0.10 | $10.8M | 2 |
| Next quarter (ends Dec 2026) | $-0.57 | $-0.46 | −$0.11 | $11.4M | 2 |
| Current fiscal year (ends Dec 2026) | $-2.28 | $-2.15 | −$0.13 | $46.9M | 2 |
| Next fiscal year (ends Dec 2027) | $-2.25 | $-2.10 | −$0.15 | $361.6M | 1 |
BETA options: expected move
Options price a move of about ±18.0% (±$3.58) by Nov 20, 2026, which includes earnings on Nov 3, 2026. Over the last 4 reports the stock moved ±3.8% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 23 | 89.0% | ±18.0% |
| Dec 18, 2026 | 51 | 79.9% | ±24.1% |
| Jan 15, 2027 | 79 | 80.5% | ±30.3% |
| Apr 16, 2027 | 170 | 80.1% | ±44.0% |
30-day implied volatility 86.9% vs 67.3% realized over the last 30 trading days. Put/call ratio (volume) 1.39. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 07:20 UTC)
| Price | USD 19.98 |
|---|---|
| Change | ▼ 3.71% (down) |
| Previous Close | USD 20.75 |
| Open | USD 20.88 |
| Day Range | USD 19.83 – 21.05 |
| 52-Week Range | USD 13.43 – 39.5 |
| Volume | 1,576,073 shares |
| Market Cap | $4.67B |
| Exchange | NYQ |
Technical Analysis (BETA)
Nexqual's technical model rates BETA "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 29, 2026 at 07:20 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.62 (neutral) |
| vs SMA50 | Below (USD 21.08) |
| MACD | -0.46 (negative) |
Analyst Ratings (BETA)
Wall Street analysts rate BETA "Buy" based on 9 analysts, with a mean price target of USD 32.22 (range USD 28–37), per Nexqual as of October 29, 2026 at 07:20 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 32.22 |
| High Target | USD 37 |
| Low Target | USD 28 |
| Buy / Hold / Sell | 9 / 0 / 0 |
Earnings (BETA)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD -0.62 |
| Revenue Estimate | $10.77M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.46 vs est -0.56 ▲ beat |
| 2026-03-31 | USD -0.4 vs est -0.74 ▲ beat |
| 2025-12-31 | USD -1.71 vs est -0.47 ▼ miss |
| 2025-09-30 | USD -1.94 vs est -0.44 ▼ miss |
Source: Nexqual, October 29, 2026 at 07:20 UTC.
Financials & Fundamentals (BETA)
| Total Revenue | $44.84M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +145.70% |
| Gross Margin | +60.06% |
| Operating Margin | -1078.71% |
| Profit Margin | +0.00% |
| ROE | -89.94% |
| Debt / Equity | 0.13 |
| Current Ratio | 14.47 |
| Total Cash | $1.48B |
| Total Debt | $206.70M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$421.53M (-940.0% of revenue) |
Source: Nexqual, October 29, 2026 at 07:20 UTC.
Financial Health Score (BETA)
Nexqual rates BETA Technologies, Inc.'s overall financial health "Mixed" across five dimensions, as of October 29, 2026 at 07:20 UTC.
| Growth | Strong — Revenue +146% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $1.48B cash and investments vs $184M debt (Jun 2026, SEC), net cash |
| Cash Flow | Weak — FCF negative: -$422M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -53%, ROA -44.4% (last 4 quarters, SEC) |
Ownership (BETA)
| Insider Ownership | +39.65% |
|---|---|
| Institutional Ownership | +37.65% |
| Shares Outstanding | 225.44M |
| Float | 124.56M |
| Short % of Float | +9.93% |
Source: Nexqual, October 29, 2026 at 07:20 UTC.
Leadership (BETA)
BETA Technologies, Inc. is led by Kyle B. Clark, Founder, CEO, President & Director, per Nexqual as of October 29, 2026 at 07:20 UTC.
| Founder, CEO, President & Director | Kyle B. Clark |
|---|---|
| Chief Financial Officer | Herman V. Cueto |
| CTO & Executive Director | David Churchill |
| Chief Operating Officer | Sean Donovan |
Major Backers & Investors (BETA)
Notable institutional backers of BETA Technologies, Inc. include FMR, LLC, General Electric Company, TPG GP A, LLC, according to Nexqual as of October 29, 2026 at 07:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 14.79% |
| General Electric Company | 9.01% |
| TPG GP A, LLC | 7.27% |
| Fidelity | 7.09% |
| Amazon.com, Inc. | 5.21% |
| T. Rowe Price | 1.01% |
| HITE Hedge Asset Management LLC | 0.84% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.65% |
| BlackRock | 1.3% |
| State Street | 1.14% |
Source: Nexqual, October 29, 2026 at 07:20 UTC.
From BETA Technologies, Inc.'s Latest SEC 10-K Filing (filed 2026-03-09)
Key Strengths & Strategy (as disclosed to the SEC)
- For example, if operated for 20 years, we estimate a typical electric aircraft will require 18 to 20 sets of replacement batteries, generating approximately $13 million in revenue assuming replacement of batteries for all customer use cases every year at current year pricing levels with a 2.5% annual escalation.
- To this end, we have developed a series of charging infrastructure, including large Charge Cubes designed for stationary charging, Mini Cubes designed for more mobile applications and thermal management systems, which cool batteries during high-speed charging.
- We have developed and manufactured proprietary battery packs and energy storage systems in-house since 2019, with an emphasis on designing for long-range eVTOL and eCTOL applications.
- The Final Assembly Facility is vertically integrated, enabling us to build all wire harnesses, assemble flight control computers, build inverters and electronic assemblies, manufacture our electric engines, assemble our battery packs and perform aircraft structural assembly and final assembly in-house.
Partnerships
- We have partnered with GE Aerospace to co-develop a hybrid electric turbogenerator, specifically designed for defense and civil applications.
- In conjunction with this partnership, GE Aerospace has made an equity investment of $300 million in BETA.
Legal & Regulatory Risks (Item 1A, quoted)
- We may become subject to product liability claims, which could harm our business, reputation, results of operations, liquidity, financial condition and prospects if we are not able to successfully defend or insure against such claims.
- We are subject to evolving privacy laws, which subjects us to a number of potential regulatory and reputational risks. We may face investigations, fines and sanctions as a result of our or our service providers' actual or perceived failure to comply with the Privacy Laws and incur increased operational costs in order to ensure future compliance.
- Increasing scrutiny, regulatory requirements and changing expectations from various stakeholders with respect to sustainability and other environmental, social and governance matters may impose additional costs on us or expose us to reputational or other risks.
- We may in the future become subject to legal proceedings, which may be time-consuming and expensive and, if adversely determined, could delay, limit or prevent our ability to commercialize our aircraft or otherwise execute on our business plans.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SARO | StandardAero, Inc. | USD 22.21 | ▼ 0.94% |
| KTOS | Kratos Defense & Security Solut | USD 41.17 | ▼ 0.36% |
| CAE | CAE Inc | USD 25.76 | ▲ 0.08% |
| DRS | Leonardo DRS, Inc. | USD 35.5 | ▼ 1.36% |
| HII | Huntington Ingalls Industries, | USD 279.26 | ▼ 0.73% |
| MOG-B | Moog Inc. | USD 350.17 | ▼ 1.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 07:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt